Ivan Marcipar
Overview
Explore the profile of Ivan Marcipar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borgna E, Prochetto E, Gamba J, Vermeulen E, Poncini C, Cribb P, et al.
Front Immunol
. 2024 Nov;
15:1484290.
PMID: 39555082
To date, there is no licensed vaccine against the protozoan parasite (, the etiological agent of Chagas Disease. has evolved numerous mechanisms to evade and manipulate the host immune system....
2.
Pacini M, Bulfoni Balbi C, Dinatale B, Farre C, Cacik P, Gonzalez F, et al.
Vaccines (Basel)
. 2024 Oct;
12(10).
PMID: 39460337
Chagas disease, caused by , leads to severe complications in 30% of infected individuals, including acute myocarditis and chronic fibrosing cardiomyopathy. Despite the significant burden of this disease, there is...
3.
Bontempi I, Arias D, Castro G, Peverengo L, Diaz G, Allassia M, et al.
PLoS Negl Trop Dis
. 2024 Jun;
18(6):e0012020.
PMID: 38924064
Bovine trypanosomosis, caused by Trypanosoma vivax, currently affects cattle and has a significant economic impact in sub-Saharan Africa and South America. The development of new diagnostic antigens is essential to...
4.
Borgna E, Gamba J, Prochetto E, Marcipar I, Cabrera G
Methods Cell Biol
. 2024 Mar;
184:59-68.
PMID: 38555158
Myeloid-derived suppressor cells (MDSCs) comprise a heterogeneous population of myeloid origin and immature state, whose hallmark is the capacity to suppress T cells and other immune populations. In mice, the...
5.
Pacini M, Perdomini A, Bulfoni Balbi C, Dinatale B, Herrera F, Perez A, et al.
Proteins
. 2023 Jun;
91(10):1444-1460.
PMID: 37323089
Trans-sialidase (TS) superfamily of proteins comprises eight subgroups, being the proteins of Group-I (TS-GI) promising immunogens in vaccine approaches against Trypanosoma cruzi. Strikingly, TS-GI antigenic variability among parasite lineages and...
6.
Borgna E, Prochetto E, Gamba J, Marcipar I, Cabrera G
Int Rev Cell Mol Biol
. 2023 Mar;
375:117-163.
PMID: 36967151
Chagas disease (CD), caused by the protozoan parasite Trypanosoma cruzi, is the third largest parasitic disease burden globally. Currently, more than 6 million people are infected, mainly in Latin America,...
7.
Pacini M, Bulfoni Balbi C, Dinatale B, Gonzalez F, Prochetto E, De Hernandez M, et al.
Acta Trop
. 2023 Mar;
241:106889.
PMID: 36893830
Trypanosoma cruzi, the agent of Chagas disease, can infect through conjunctive or oral mucosas. Therefore, the induction of mucosal immunity by vaccination is relevant not only to trigger local protection...
8.
Lupi G, Santiago Valtierra F, Cabrera G, Spinelli R, Siano A, Gonzalez V, et al.
Vet Immunol Immunopathol
. 2022 Jul;
251:110460.
PMID: 35901545
Low-cost adjuvants are urgently needed for the development of veterinary vaccines able to trigger strong immune responses. In this work, we describe a method to obtain a low-cost cage-like particles...
9.
Sonzogni A, Cabrera G, Lupi G, Gugliotta L, Gonzalez V, Marcipar I, et al.
Macromol Biosci
. 2022 Apr;
22(6):e2100515.
PMID: 35388617
Transcutaneous immunization (TCI) provides a valuable alternative approach to conventional vaccination because of the high accessibility and the exceptional immunological characteristics of the skin, but its application is limited by...
10.
Pacini M, Gonzalez F, Dinatale B, Bulfoni Balbi C, Villar S, Farre C, et al.
Vaccine
. 2022 Mar;
40(15):2311-2323.
PMID: 35279330
The new generation of vaccines for Chagas disease, are focused to induce both humoral and cellular response to effectively control Trypanosoma cruzi parasites. The administration of vaccine formulations intranasally has...